Lv11
70 积分 2022-02-28 加入
Tislelizumab Plus Chemotherapy vs Chemotherapy Alone as First-line Treatment for Advanced Squamous Non–Small-Cell Lung Cancer
1小时前
待确认
Adrenal insufficiency: identification and management—summary of new NICE guidance
1个月前
已完结
Abstract CT053: Aumolertinib with or without chemotherapy as first line treatment in locally advanced or metastatic NSCLC with sensitizing EGFR mutations (AENEAS2)
2个月前
已完结
[Expert consensus on the diagnosis and treatment of advanced non-small cell lung cancer with EGFR PACC mutations (2025 edition)]
4个月前
已完结
Sacituzumab tirumotecan versus docetaxel for previously treated EGFR -mutated advanced non-small cell lung cancer: multicentre, open label, randomised controlled trial
5个月前
已完结
A pooled analysis of datopotamab deruxtecan in patients with EGFR–mutated NSCLC
5个月前
已完结
皖公网安备34019202002308
